增强DTC病灶摄取131I功能的措施

The augmentation of 131I uptake of DTC

  • 摘要: 甲状腺癌是常见的内分泌系统恶性肿瘤,其中分化型甲状腺癌(DTC)约占80%。目前治疗DTC的最佳方案为甲状腺近全切除术+131I治疗+甲状腺激素抑制治疗,这种综合治疗可以有效地降低DTC的复发率。DTC的131I治疗包括两个方面,一是术后残留甲状腺的去除,二是转移灶的治疗。重组人促甲状腺激素、利尿剂、碳酸锂、维甲酸等四类药物可用于增强DTC术后残余甲状腺与转移灶摄取131I的功能,研究表明,这些措施的应用可以明显提高疗效。

     

    Abstract: Thyroid cancer is one of the most common endocrinal carcinomas, and the differentiated thyroid carcinoma (DTC) is about 80 percent of it. The up-to-date scheme of DTC therapy is surgery+radioiodine therapy+thyroxine inhibition, it effectively reduce the risk of recurrence of DTC. Radioiodine therapy of DTC include two aspects, one is the ablation of thyroid remnant and the other is the therapy of metastasis. The methods to increase the radioiodine uptake in lesions of DTC are reviewed in this article. Studys suggest these methods could increase the uptake of radioiodine in lesions of DTC obviously.

     

/

返回文章
返回